Tags

Type your tag names separated by a space and hit enter

[Evidence-based recommendations for the treatment of depressive comorbidity in somatic illness].
Internist (Berl) 2019; 60(12):1226-1234I

Abstract

BACKGROUND

Comorbid depression is frequent in internal medicine (e.g. in coronary heart disease, congestive heart failure or diabetes mellitus) and impairs quality of life as well as the prognosis of the somatic illness.

AIM

To review evidence based recommendations for the treatment of depressive comorbidity in selected somatic disorders.

MATERIALS AND METHODS

Selective literature search based on national and international guidelines.

RESULTS

In clinical routine, depressive symptoms are often overseen or misinterpreted. Therefore, a specific diagnostic is recommended. Depressive symptoms should obligatory be screened during the clinical interview or by validated questionnaires. When screened positive, further diagnostic steps are mandatory. The treatment of depressive disorders has three main components: basic psychosomatic care, psychotherapy and antidepressant medication. These interventions are safe and effective for reducing depressive symptoms and enhancing quality of life. However, results regarding the effects on morbidity and mortality of the comorbid somatic disorder are still inconclusive. The greatest effects on depression are obtained by a preference-based, stepped-care approach and an optimal cooperation of all professionals ("collaborative care").

CONCLUSIONS

An effective treatment of depressive comorbidity is relevant for quality of life and possibly also for the prognosis of a somatic disease. Integrating a routine screening for depressive symptoms is the first step toward an effective, evidence-based therapy.

Authors+Show Affiliations

Klinik und Poliklinik für Psychosomatik und Psychotherapie, Uniklinik Köln, Köln, Deutschland. christian.albus@uk-koeln.de.Klinik und Poliklinik für Psychosomatik und Psychotherapie, Universitätsklinikum Bonn, Bonn, Deutschland.

Pub Type(s)

English Abstract
Journal Article
Review

Language

ger

PubMed ID

31664464

Citation

Albus, C, and F Geiser. "[Evidence-based Recommendations for the Treatment of Depressive Comorbidity in Somatic Illness]." Der Internist, vol. 60, no. 12, 2019, pp. 1226-1234.
Albus C, Geiser F. [Evidence-based recommendations for the treatment of depressive comorbidity in somatic illness]. Internist (Berl). 2019;60(12):1226-1234.
Albus, C., & Geiser, F. (2019). [Evidence-based recommendations for the treatment of depressive comorbidity in somatic illness]. Der Internist, 60(12), pp. 1226-1234. doi:10.1007/s00108-019-00694-y.
Albus C, Geiser F. [Evidence-based Recommendations for the Treatment of Depressive Comorbidity in Somatic Illness]. Internist (Berl). 2019;60(12):1226-1234. PubMed PMID: 31664464.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Evidence-based recommendations for the treatment of depressive comorbidity in somatic illness]. AU - Albus,C, AU - Geiser,F, PY - 2019/10/31/pubmed PY - 2019/10/31/medline PY - 2019/10/31/entrez KW - Depression screening KW - Diabetes mellitus KW - Heart diseases KW - Psychosomatic care KW - Psychotherapy SP - 1226 EP - 1234 JF - Der Internist JO - Internist (Berl) VL - 60 IS - 12 N2 - BACKGROUND: Comorbid depression is frequent in internal medicine (e.g. in coronary heart disease, congestive heart failure or diabetes mellitus) and impairs quality of life as well as the prognosis of the somatic illness. AIM: To review evidence based recommendations for the treatment of depressive comorbidity in selected somatic disorders. MATERIALS AND METHODS: Selective literature search based on national and international guidelines. RESULTS: In clinical routine, depressive symptoms are often overseen or misinterpreted. Therefore, a specific diagnostic is recommended. Depressive symptoms should obligatory be screened during the clinical interview or by validated questionnaires. When screened positive, further diagnostic steps are mandatory. The treatment of depressive disorders has three main components: basic psychosomatic care, psychotherapy and antidepressant medication. These interventions are safe and effective for reducing depressive symptoms and enhancing quality of life. However, results regarding the effects on morbidity and mortality of the comorbid somatic disorder are still inconclusive. The greatest effects on depression are obtained by a preference-based, stepped-care approach and an optimal cooperation of all professionals ("collaborative care"). CONCLUSIONS: An effective treatment of depressive comorbidity is relevant for quality of life and possibly also for the prognosis of a somatic disease. Integrating a routine screening for depressive symptoms is the first step toward an effective, evidence-based therapy. SN - 1432-1289 UR - https://www.unboundmedicine.com/medline/citation/31664464/[Evidence-based_recommendations_for_the_treatment_of_depressive_comorbidity_in_somatic_illness] L2 - https://dx.doi.org/10.1007/s00108-019-00694-y DB - PRIME DP - Unbound Medicine ER -